Literature DB >> 2648391

Human immunodeficiency viral long terminal repeat is functional and can be trans-activated in Escherichia coli.

F Kashanchi1, C Wood.   

Abstract

The long terminal repeat (LTR) of the human immunodeficiency virus (HIV) contains the viral promoter, which is responsible for viral gene expression in eukaryotic cells. We have demonstrated that HIV LTR can also function as a promoter in Escherichia coli. A recombinant plasmid containing the HIV LTR linked to the chloramphenicol acetyltransferase gene can express the enzyme efficiently upon transformation into bacteria. Mung bean nuclease analysis mapped the bacterial transcriptional start site of the promoter to the U3 region of the LTR, in contrast to transcription in eukaryotic cells, which initiates in the U3-R boundary of the LTR. The HIV LTR, besides being fully functional in E. coli, can also be specifically trans-activated by the HIV tat gene product. Trans-activation is demonstrated by an increase in chloramphenicol acetyltransferase activity as well as an increase in the mRNA level of the enzyme. This trans-activation of HIV LTR by tat protein in bacteria offers a useful system to investigate further the specific interaction between tat protein with HIV LTR and the mechanisms of trans-activation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2648391      PMCID: PMC286870          DOI: 10.1073/pnas.86.7.2157

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  HIV/HTLV gene nomenclature.

Authors:  R Gallo; F Wong-Staal; L Montagnier; W A Haseltine; M Yoshida
Journal:  Nature       Date:  1988-06-09       Impact factor: 49.962

Review 2.  Compilation and analysis of Escherichia coli promoter DNA sequences.

Authors:  D K Hawley; W R McClure
Journal:  Nucleic Acids Res       Date:  1983-04-25       Impact factor: 16.971

3.  Molecular cloning and expression of Bacillus licheniformis beta-lactamase gene in Escherichia coli and Bacillus subtilis.

Authors:  O Gray; S Chang
Journal:  J Bacteriol       Date:  1981-01       Impact factor: 3.490

4.  An avian tumor virus promoter directs expression of plasmid genes in Escherichia coli.

Authors:  S A Mitsialis; J F Young; P Palese; R V Guntaka
Journal:  Gene       Date:  1981-12       Impact factor: 3.688

5.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

6.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

7.  Molecular cloning with bifunctional plasmid vectors in Bacillus subtilis. I. Construction and analysis of B. subtilis clone banks in Escherichia coli.

Authors:  G R Ostroff; J J Pène
Journal:  Mol Gen Genet       Date:  1984

8.  Evidence for a prokaryotic promoter in the murine mammary tumor virus long terminal repeat.

Authors:  O Prakash; R V Guntaka; N H Sarkar
Journal:  Gene       Date:  1983-08       Impact factor: 3.688

9.  A cDNA cloning vector that permits expression of cDNA inserts in mammalian cells.

Authors:  H Okayama; P Berg
Journal:  Mol Cell Biol       Date:  1983-02       Impact factor: 4.272

10.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

Authors:  M Popovic; M G Sarngadharan; E Read; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

View more
  5 in total

Review 1.  External guide sequence technology: a path to development of novel antimicrobial therapeutics.

Authors:  Carol Davies-Sala; Alfonso Soler-Bistué; Robert A Bonomo; Angeles Zorreguieta; Marcelo E Tolmasky
Journal:  Ann N Y Acad Sci       Date:  2015-04-09       Impact factor: 5.691

2.  Identification of cellular proteins that bind to the human immunodeficiency virus type 1 trans-activation-responsive TAR element RNA.

Authors:  A Gatignol; A Kumar; A Rabson; K T Jeang
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

3.  Transactivation of the human immunodeficiency virus promoter by human herpesvirus 6 (HHV-6) strains GS and Z-29 in primary human T lymphocytes and identification of transactivating HHV-6(GS) gene fragments.

Authors:  R T Horvat; C Wood; S F Josephs; N Balachandran
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

4.  Identification and characterization of a human herpesvirus 6 gene segment that trans activates the human immunodeficiency virus type 1 promoter.

Authors:  Y Q Geng; B Chandran; S F Josephs; C Wood
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

5.  Extinction of the HPV18 upstream regulatory region in cervical carcinoma cells after fusion with non-tumorigenic human keratinocytes under non-selective conditions.

Authors:  F Rösl; T Achtstätter; T Bauknecht; K J Hutter; G Futterman; H zur Hausen
Journal:  EMBO J       Date:  1991-06       Impact factor: 11.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.